HOME >> MEDICINE >> NEWS
Nitrosamines Play Important Role In Cancer Linked To Smoking

nitrosamines, more effective approaches toward prevention of tobacco-related cancers can be designed. Because lung cancer therapy is still largely unsuccessful, the use of chemical agents to inhibit the carcinogenicity of tobacco smoke--called chemoprevention--remains as a viable way to prevent cancer death in addicted smokers and ex-smokers, Hecht adds. Many agents have been tested in mice, and phase I clinical trials for the leading candidate, an isothiocyanate called PEITC, are being initiated.

# # # #

Researcher contact: Dr. Stephen S. Hecht,
612-624-7604 (phone); 612-626-5135 (fax);
hecht002@gold.tc.umn.edu (email);

or Coleen Southwell,
Director of Communications, University of Minnesota Cancer Center
612-626- 1107;
south011@tc.umn.edu

For a copy of an earlier release on Dr. Hecht's research on nitrosamines and environmental tobacco smoke, or a copy of this 45-page review, call Sally Pecor at 202-872-4451.


'"/>

Contact: Jim Bohning
j_bohning@acs.org
202/872-6041
American Chemical Society
2-Jun-1998


Page: 1 2

Related medicine news :

1. Important priorities for prevention and treatment of HIV/AIDS
2. Important information to consider about non-systemic cholesterol lowering agents
3. Important advances in the development of drug delivery vehicles
4. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
5. Cancer in patients with hepatitis C
6. Olson family donates $1 million to Arizona Cancer Center
7. Cancer vaccines: A two-pronged attack?
8. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
9. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
10. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
11. Cancer researchers seek to predict tumor growth

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nitrosamines Play Important Role Cancer Linked Smoking

(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: